コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 or both MMP-9 and metalloproteinase-2 (MMP-2/gelatinase A).
2 MMP-1 (interstitial collagenase) and MMP-2 (gelatinase A).
3 not with matrix metalloproteinase 2 (MMP-2, gelatinase A).
4 in both the production and release of MMP-2 (gelatinase A).
5 he expression of metalloproteinase-2 (MMP-2, gelatinase A).
6 n lattice (dermal equivalent) secrete active gelatinase A.
7 ses, and by BB3003, a selective inhibitor of gelatinase A.
8 embrane-anchored enzyme and an activator for gelatinase A.
9 th the proenzyme form and the active form of gelatinase A.
10 complete inhibition of activation of latent gelatinase A.
11 rotease that was historically referred to as gelatinase A.
12 iated adipocytes expressed an activated MMP, gelatinase A.
13 ent work shows that these cells also secrete gelatinase A.
14 r mixtures of MMPs such as collagenase 3 and gelatinase A.
15 P-2 binding and subsequent activation of pro-gelatinase A.
16 surface and initiating the activation of pro-gelatinase A.
17 e matrix metalloproteinases (MMP), including gelatinase A (72-kDa type IV collagenase) as inactive zy
21 h (a furin inhibitor) did not affect the pro-gelatinase A activation mechanism in COS-1 cells cotrans
22 MMP expression might contribute, in part, to gelatinase A activation, which in turn facilitates invas
32 es and in a tonsillar cell suspension, while gelatinase A and interstitial collagenase activities wer
33 the distribution and relative expression of gelatinase A and its associated inhibitor, tissue inhibi
34 n treatment resulted in the up-regulation of gelatinase A and macrophage metalloelastase gene express
35 we investigated the expression of activated gelatinase A and membrane-type metalloproteinase (MT-MMP
36 NSE) on two matrix metalloproteinases, MMP-2/gelatinase A and MMP-9/gelatinase B, which are known to
38 Expression of the matrix metalloproteinases gelatinase A and stromelysin-1 and the serine proteinase
45 used a NIRF substrate for gelatinases (MMP-2/gelatinase-A and MMP-9/gelatinase-B) in apolipoprotein E
46 irst evidence that normal mast cells express gelatinases A and B and suggest pathways by which their
48 levels within 18 h, while the expression of gelatinases A and B remained unchanged, suggesting that
51 increases expression and activity of MMP-2 (gelatinase A) and -9 (gelatinase B) in cardiac fibroblas
52 levels of matrix metalloproteinase (MMP)-2 (gelatinase A) and -9 (gelatinase B) were synthesized and
53 forms of matrix metalloproteinase-2 (MMP-2, gelatinase A) and do not react with unrelated proteins i
54 other MMPs (stromelysin-1, stromelysin-3 and gelatinase A) and MMP inhibitors (TIMP-1 and TIMP-2) wer
55 proteinases (MMPs) and, specifically, MMP-2 (gelatinase A) and MMP-9 (gelatinase B) are strongly asso
57 tion analysis was conducted for stromelysin, gelatinase A, and gelatinase B with the various inhibito
58 ates production of interstitial collagenase, gelatinase A, and stromelysin-1 by fibroblasts, and we h
59 d in collagen lattices contain active 62-kDa gelatinase A at least 4-6 h before active enzyme is dete
60 r this inconsistency is that the bulk of the gelatinase A binding depends on its ability to diffuse l
62 en used to analyze the rate of inhibition of gelatinase A by TIMP-2 over a wide range of TIMP-2 conce
63 of inhibition of matrix metalloproteinase-2 (gelatinase A) by tissue inhibitor of metalloproteinase-2
64 med to be matrix metalloproteinase-2 (MMP-2; gelatinase A) by Western blotting and immunoprecipitatio
74 n vivo distribution of type VII collagen and gelatinase A (Gel A) in the developing human epidermis a
80 xpression of MMP-9 (gelatinase B) and MMP-2 (gelatinase A) have been observed in Alzheimer's disease,
81 eads to the appearance of activated forms of gelatinase A in culture supernatants, and the de novo ex
85 protease, MT1-MMP (MMP-14), and that active gelatinase A is absolutely required for epithelial-mesen
88 transmembrane MMP that activates pro-MMP-2 (gelatinase A), is expressed in human atherosclerotic pla
89 alloproteinase (MMP)-2 (type IV collagenase; gelatinase A), is implicated in tumor metastasis as well
90 te that a discrete matrix metalloproteinase, gelatinase A, is capable of inducing the complex genetic
95 e in the levels of matrix metalloproteinases gelatinase A (MMP-2) and gelatinase B (MMP-9) after part
97 and active forms of gelatinase B (MMP-9) and gelatinase A (MMP-2) and to the MMP-9 tissue inhibitor o
100 h in MEE and in adjacent mesenchyme, whereas gelatinase A (MMP-2) was expressed by mesenchymal cells
101 esis of a specific matrix metalloproteinase, gelatinase A (MMP-2), and its activator protease, MT1-MM
102 1, MT1-MMP, (MMP-14) collagenase-3 (MMP-13), gelatinase A (MMP-2), and TIMP-1, -2 and -3] was induced
103 ed immunosorbent assay) were used to measure gelatinase A (MMP-2), gelatinase B (MMP-9) and tissue in
104 (MMP-3), gelatinase B (MMP-9), and activated gelatinase A (MMP-2), in human vascular SMCs by cell con
105 tent inhibitors of stromelysin-1 (MMP-3) and gelatinase A (MMP-2), in the range of 10-50 nM, but poor
106 monoclonal antibodies against the Mr 72,000 gelatinase A (MMP-2), Mr 92,000 gelatinase B (MMP-9), an
107 hritis was found to contain at least 3 MMPs: gelatinase A (MMP-2), stromelysin (MMP-3), and gelatinas
108 ining was performed for collagenase (MMP-1), gelatinase A (MMP-2), stromelysin (MMP-3), TIMP-1, and T
109 ctions were immunostained with antibodies to gelatinase A (MMP-2), stromelysin-1 (MMP-3), and gelatin
111 ly potent against collagenase-3 (MMP-13) and gelatinase A (MMP-2), while they spared collagenase-1 (M
114 n (alpha1(I) chain), decorin (core protein), gelatinase-A (MMP-2), stromelysin-1 (MMP-3), and a tissu
115 e that stromelysin-1 (MMP-3), as well as the gelatinases A (MMP-2) and B (MMP-9), processes recombina
116 n core protein), degradative enzymes (MMP-2 [gelatinase-A], MMP-3 [stromelysin-1]), and a tissue inhi
120 any family members, including stromelysin-3, gelatinase A, MT-MMP, interstitial collagenase, and stro
124 (MT-MMP) activate the zymogen form of MMP-2/Gelatinase A on cell surfaces and are expressed in invas
125 thought to be responsible for activation of gelatinase A on the plasma membrane of tumor cells, show
126 ollagenases (MMP-1 and MMP-13), gelatinases (gelatinase A or B), stromelysins (MMP-3 and MMP-11), or
127 kDa type IV collagenase, also referred to as gelatinase A or MMP-2, has been proposed to potentiate t
129 elysin and gelatinase B but not collagenase, gelatinase A, or tissue inhibitor of metalloproteinases
133 Overexpression of YB-1 and AP2 proteins by gelatinase A synthesizing hepatoma HepG2 cells induced a
134 e dissociation of 125I-labeled TIMP-2 from a gelatinase A-TIMP-2 complex using ligand exchange experi
135 s invasion independently of plasminogen, the gelatinase A/TIMP-2 axis, gelatinase B, collagenase-3, c
136 itu hybridization indicated that most of the gelatinase A transcripts were present in the fibrous lay
137 azole urea inhibitors with stromelysin-1 and gelatinase-A, two homologous MMPs that have been implica
139 is indicated that the relative expression of gelatinase A was increased by 128% in deprived eyes (P =
141 gelatinase A, whereas the activated form of gelatinase A was only seen in metastatic lung adenocarci
143 TIMP-3 mRNA while stromelysin-3, TIMP-2 and gelatinase A were seen in the overlying connective tissu
144 of collagenase I and stromelysin I, but not gelatinase A, were inhibited in the mutant STAT3 transfe
145 samples examined contained a latent form of gelatinase A, whereas the activated form of gelatinase A
146 ntral cornea contained the proenzyme form of gelatinase A, whereas the peripheral cornea contained bo
147 will bind selectively to stromelysin-1 over gelatinase-A which is gratifying given the high degree o
148 llate cells (HSCs) are a potential source of gelatinase A, which accumulates in fibrotic livers.
149 MT1-MMP and enhanced secretion of activated gelatinase A, which reached a maximum of 44.4% of the to